Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Gemphire Therapeutics Inc.

NASDAQ: GEMPHealthcare / Biotechnology / USA
1.16+0.0100+0.87%Vol 23 9831Y Perf -82.93%
Feb 21st, 2019 15:59
BID1.15 ASK1.17
Open1.14 Previous Close1.15
Pre-Market- After-Trading-
 - -%  - -%
Target Price
2.00 
Analyst Rating
Hold 3.00
Potencial %
72.41 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)17 
Earnings Rating
Buy
Price Range Ratio 52wk %
5.43 
Earnings Date
21st Mar 2019

Today's Price Range

1.081.16

 

52wk Range

0.570011.43

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
7.41%
3 Months
-1.69%
6 Months
-25.16%
1 Year
-82.93%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
GEMP1.160.01000.87
AAPL171.06-0.9700-0.56
GOOG1 096.97-16.8300-1.51
MSFT109.412.26002.11
XOM77.82-0.7100-0.90
WFC49.56-0.2500-0.50
JNJ135.42-0.9300-0.68
FB160.04-2.5200-1.55
GE10.03-0.0700-0.69
JPM105.47-0.2200-0.21
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
3.10
Current Ratio
3.30
Long Term Debt to Total Capital
0.37
Total Debt to Equity
0.93
Interest Coverage
-
Leverage Ratio 1.90
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-
EBITDA Margin
-
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
1.46
PS Ratios
-
Price to Cash Flow
-
Price to Free Cash Flow
-0.90
Cash Flow Per Share
-1.90
Price to Tangible Book
1.46
Book Value per Share
0.76
Enterprise Value (in ths.)
2 109
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-
ROE last 12 Months
-256.97
Return on Assets (5Y Avg)
-
ROA last 12 Months
-104.65
Return on Capital (5Y Avg)
-
ROC last 12 Months
-120.05
Return on invested Capital Q
-26.33
Return on invested Capital Y
-149.68
Assets Turnover
0.00
Receivables Turnover
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
0
Revenue per Share
0.00
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.45-0.434.44
Q02 2018-0.51-0.477.84
Q01 2018-0.59-0.581.69
Q04 2017-0.72-0.6312.50
Q03 2017-0.72-0.82-13.89
Q02 2017-0.80-0.747.50
Q01 2017-0.61-0.79-29.51
Q04 2016--0.78-
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.390.00-
12/2018 FY-1.880.00-
3/2019 QR-0.420.00-
12/2019 FY-2.050.00-
Next Report Date21st Mar 2019
Estimated EPS Next Report-0.39
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume23 983
Shares Outstanding (in ths.)14 265
Trades Count86
Dollar Volume23 799
Avg. Volume70 955
Avg. Weekly Volume28 044
Avg. Monthly Volume63 501
Avg. Quarterly Volume106 192

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

39%61%

Bearish Bullish

60%40%

Bearish Bullish

55%45%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
1 (33.33 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (100.00 %)
2 (100.00 %)
2 (66.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Hold
3.00
Moderate Buy
2.33

There are no comments yet.

News